"Avoidable Deaths" - Union for International Cancer Control
"Back to Basics: The Concept of HRQL Under a Magnifying Glass" - EORTC Quality of Life Group
"Bald for a Cause" initiative - UWC Dilijan College
Vincent Rajkumar: 3 Possible Entities of Solitary Plasmacytoma with differing Prognosis in the Differential Diagnosis
ASCO24 Updates - Dr. Mohammad Jad Moussa on Small Cell Bladder Cancer: Relapse Risks and pCR Impact
Myeloma Paper of the Day, July 4th, suggested by Robert Orlowski
Dhan Chand: Collaboration and innovation in cancer treatment at SITC 2024
Palvella is the recipient of an FDA Orphan Product Grant up to $2.6 million
FDA approval of Taletrectinib for ROS1 positive Non Small Cell Lung Cancer
